Synfacts, Table of Contents Synfacts 2023; 19(07): 0727DOI: 10.1055/s-0042-1752711 Innovative Drug Discovery and Development Discovery of a Potent and Orally Bioavailable Estrogen Receptor Degrader-AntagonistsContributor(s): Antonia F. Stepan (Roche) , Ferdinand H. Lutter (Janssen Pharmaceutica)Recommend Article Abstract Buy ArticleKey words Key wordsbreast cancer treatment - zwitterion - oral bioavailability Full Text